Abstract: A lighting device includes a light board and a light dimmer circuit. The light board includes multiple first light emitting elements and second light emitting elements. The first light emitting elements are disposed in a first area of the light board. The second light emitting elements are disposed in a second area of the light board. The light dimmer circuit is configured to drive the second light emitting elements to generate flickering lights from the second area of the light board, and is configured to drive the first light emitting elements to generate non-flickering lights from the first area of the light board.

Abstract: In an example implementation, the method includes automatically determining whether a computer system is located on-premises of a health service provider or on a multi-tenant cloud. The method includes communicatively coupling with health service provider data sources via a local network and extracting health service provider data from them. The health service provider data may include protected health information (PHI) and non-PHI data. The method includes storing the PHI data and the non-PHI data in an on-premises operational data store that is located on-premises of the health service provider. The method includes obtaining data analytics based on the PHI data and the non-PHI data stored in the on-premises operational data store. The method also includes communicatively coupling with a multi-tenant cloud via a global network and synchronizing the non-PHI data in the on-premises operational data store with the multi-tenant cloud via the global network.

Abstract: In an example implementation, the method includes automatically determining whether a computer system is located on-premises of a health service provider or on a multi-tenant cloud. The method includes communicatively coupling with health service provider data sources via a local network and extracting health service provider data from them. The health service provider data may include protected health information (PHI) and non-PHI data. The method includes storing the PHI data and the non-PHI data in an on-premises operational data store that is located on-premises of the health service provider. The method includes obtaining data analytics based on the PHI data and the non-PHI data stored in the on-premises operational data store. The method also includes communicatively coupling with a multi-tenant cloud via a global network and synchronizing the non-PHI data in the on-premises operational data store with the multi-tenant cloud via the global network.

Abstract: In an example implementation, a method includes communicatively coupling a tenant instance of a multi-tenant cloud with a corresponding agent that is located on-premises of a health service provider via a global network. The method includes synchronizing the tenant instance with the agent including receiving non-Protected Health Information (non-PHI) data absent Protected Health Information (PHI) data from the agent at the tenant instance via the global network. The method includes extracting the non-PHI data from the agent into a cloud-based operational data store of the tenant instance that corresponds to the agent. The method includes storing the non-PHI data in the cloud-based operational data store. The method includes analyzing the non-PHI data in the cloud-based operational data store by load-balanced services.

Abstract: Disclosed is a photo-stimulation method employing an agonist agent, and a kit for introducing same. The method includes the following steps: providing a light-emitting diode (LED) illuminant which is a yellow, red, green, blue LED or a mixture of two or more kinds thereof, and an agonist agent which contains 0.5% to 2% calcium ion; and adding the agonist agent to a subject and illuminating the subject by the LED illuminant to promote collagen synthesis, to suppress microbial growth, or to inhibit melanin synthesis, wherein the yellow LED is in an illuminance range from 1,000 to 3,500 lux, the red LED is in an illuminance range from 6,000 to 9,500 lux, the green LED is in an illuminance range from 1000 to 5000 lux, and the blue LED is in an illuminance range from 3,000 to 7,000 lux.

Abstract: Disclosed is a photo-stimulation method and device with a light mixture. The method includes the following steps: providing a light-emitting diode (LED) illuminant which is a combination of a yellow LED and a red LED; and illuminating a subject by the LED illuminant to promote collagen synthesis, to suppress microbial growth, or to inhibit melanin synthesis, wherein the yellow LED is in an illuminance range from 1,000 to 3,500 lux, the red LED is in an illuminance range from 6,000 to 9,500 lux, and the number ratio of the yellow LED to the red LED is 0.5-2:0.5-2.

Abstract: Disclosed is a photo-stimulation method and device. The method includes the following steps: providing a light-emitting diode (LED) illuminant which is a yellow, red, or blue LED; and illuminating a subject by the LED illuminant to promote collagen synthesis, to suppress microbial growth, or to inhibit melanin synthesis, wherein the yellow LED is in an illuminance range from 1,000 to 3,500 lux, the red LED is in an illuminance range from 6,000 to 9,500 lux, and the blue LED is in an illuminance range from 3,000 to 7,000 lux.